News Details

BeiGene to Participate in Goldman Sachs 37th Annual Global Healthcare Conference    read more...

BeiGene Presents Initial Clinical Data on PD-1 Antibody BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting    read more...

BeiGene Announces Presentation on BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting    read more...

BeiGene Reports First Quarter 2016 Financial Results    read more...

BeiGene Appoints Dr. Ji Li as Executive Vice President, Global Head of Business Development    read more...

BeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting    read more...

BeiGene Appoints Eric Hedrick, M.D. as Interim Chief Medical Officer    read more...

BeiGene Announces Closing of Its Initial Public Offering    read more...